Evaxion A/S
EVAX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001828253
No open-market purchases or sales by Evaxion A/S insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.93M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Evaxion A/S changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 6 | 8 | +2 |
| Shares | 453.3K | 548.5K | +95.1K (+21.0%) |
| Value | $1.31M | $1.71M | +$392.3K (+29.9%) |
New holders (2)
Institutions that held Evaxion A/S at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 14,825 | $46.1K | 0.00% |
| BlackRock, Inc. | 1,512 | $4.70K | 0.00% |
Sold out (0)
Institutions that held Evaxion A/S at the end of Q2 2024 and filed for Q3 2024 without it.
None.